<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Plasma nonesterified fatty acids (NEFA) at elevated concentrations antagonize insulin action and thus may play a critical role in the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma NEFA and <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations are regulated, in part, by their uptake into peripheral tissues </plain></SENT>
<SENT sid="2" pm="."><plain>Cellular energy uptake can be increased by enhancing either energy transport or metabolism </plain></SENT>
<SENT sid="3" pm="."><plain>The effects of overexpression of <z:chebi fb="0" ids="35759">1-acylglycerol</z:chebi>-3-phosphate acyltransferase (AGAT)-alpha, which catalyzes the second step in <z:chebi fb="0" ids="17855">triglyceride</z:chebi> formation from <z:chebi fb="3" ids="17754">glycerol</z:chebi>-3-phosphate, was studied in 3T3-L1 adipocytes and C2C12 myotubes </plain></SENT>
<SENT sid="4" pm="."><plain>In myotubes, overexpression of AGAT-alpha did not affect total [<z:chebi fb="32" ids="36927">14C</z:chebi>]<z:chebi fb="105" ids="17234">glucose</z:chebi> uptake in the presence or absence of insulin, whereas insulin-stimulated [<z:chebi fb="32" ids="36927">14C</z:chebi>]<z:chebi fb="105" ids="17234">glucose</z:chebi> conversion to cellular <z:chebi fb="23" ids="18059">lipids</z:chebi> increased significantly (33%, P = 0.004) with a concomitant decrease (-30%, P = 0.005) in <z:chebi fb="15" ids="28087">glycogen</z:chebi> formation </plain></SENT>
<SENT sid="5" pm="."><plain>[3H]<z:chebi fb="0" ids="16196">oleic acid</z:chebi> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e>) uptake in AGAT-overexpressing myotubes increased 34% (P = 0.027) upon insulin stimulation </plain></SENT>
<SENT sid="6" pm="."><plain>AGAT-alpha overexpression in adipocytes increased basal (130%, P = 0.04) and insulin-stimulated (27%, P = 0.01) [3H]<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> uptake, increased insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake (56%, P = 0.04) and conversion to cellular <z:chebi fb="23" ids="18059">lipids</z:chebi> (85%, P = 0.007), and suppressed basal (-44%, P = 0.01) and <z:chebi fb="0" ids="6046">isoproterenol</z:chebi>-stimulated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> release (-45%, P = 0.03) but not <z:chebi fb="3" ids="17754">glycerol</z:chebi> release </plain></SENT>
<SENT sid="7" pm="."><plain>Our data indicate that an increase in metabolic flow to <z:chebi fb="0" ids="17855">triglyceride</z:chebi> synthesis can inhibit NEFA release, increase NEFA uptake, and promote insulin-mediated <z:chebi fb="105" ids="17234">glucose</z:chebi> utilization in 3T3-L1 adipocytes </plain></SENT>
<SENT sid="8" pm="."><plain>In myotubes, however, AGAT-alpha overexpression does not increase basal cellular energy uptake, but can enhance NEFA uptake and divert <z:chebi fb="105" ids="17234">glucose</z:chebi> from <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthesis to lipogenesis upon insulin stimulation </plain></SENT>
</text></document>